Clinical trial
Cranberry for Prevention of Urinary Tract Infections in Multiple Sclerosis…
NCT00280592 · Rennes University Hospital, Other · Completed
Key facts
| NCT number | NCT00280592 |
|---|---|
| Title | Cranberry for Prevention of Urinary Tract Infections in Multiple Sclerosis Patients |
| Official title | Prospective, Randomized, Double-blind, Placebo-controlled Study on Parallel Groups Evaluating the Efficacy and Safety of Cranberry (Vaccinium Macrocarpon) in Prevention of Urinary Tract Infections in Multiple Sclerosis Patients. |
| Acronym | CANNEBERGE |
| Lead sponsor | Rennes University Hospital, Other |
| Collaborators | Pierre Fabre Laboratories Industry Ministry of Health, France |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Multiple Sclerosis, Urinary Tract Infections, Bladder Dysfunction |
| Intervention type | Drug |
| Interventions | Cranberry, Placebo |
| Enrollment | 171 |
| Start date | Jan 1, 2006 |
| Primary completion | Mar 1, 2008 |
| Completion | Oct 1, 2008 |
| First posted | Jan 23, 2006 |
| Last update posted | May 21, 2012 |
| Countries | France |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: